Publications by authors named "David Carbone"

Claim this Profile
E
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients.
Anet Greib, Songzhu Zhao, Michelle Ploch, Jonathan Henricks, Robert Easterling, David P Carbone

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy.
Adam Khorasanchi, Mingjia Li, Songzhu Zhao, Lai Wei, Evelyn Goodyear, David P Carbone

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer.
Dwight H Owen, Ruohan Wu, Lai Wei, Mikhail Dikov, Shankar Suman, David P Carbone

Invest New Drugs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United States.
Alexander J Didier, Charlotte Lennox, Mingjia Li, Jinesh Gheeya, Asrar Alahmadi, David P Carbone

Cancer Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation.
Zhaojun Qiu, No-Joon Song, Anqi Li, Deepika Singh, Chandra B Prasad, David P Carbone

J Clin Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung Cancer.
John Sharp, Philip Young, Songzhu Zhao, Lai Wei, Sandip H Patel, David P Carbone

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database. [Journal of Thoracic Oncology Vol. 20 No. 10: 1423-1440]".
David P Carbone, Fred R Hirsch, Raymond Uyiosa Osarogiagbon, Katherine K Nishimura, Ming Sound Tsao

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employment of artificial intelligence for early lung cancer diagnosis: a retrospective cohort study.
Nathan R Hill, Travis Dotson, Sarah E Maus, Christina Bellinger, Vishisht Mehta, David P Carbone

BMJ Open Respir Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.
Celine Mascaux, Triparna Sen, Montse Sanchez-Cespedes, Sandra Ortiz-Cuaran, Yohan Bossé, David P Carbone

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database.
David P Carbone, Fred R Hirsch, Raymond Uyiosa Osarogiagbon, Katherine K Nishimura, Ming Sound Tsao

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors.
Sandip H Patel, Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, David P Carbone

Cancer Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations.
Po-Lan Su, Peiran Xu, Chien-Chung Lin, Christian Rolfo, David P Carbone

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers.
No-Joon Song, Juan Xie, Kyeong Joo Jung, Yi Wang, Joanna Pozniak, David P Carbone

Cancer Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies.
Mingjia Li, Po-Lan Su, Songzhu Zhao, Grace Cheng, Nicholas Jones, David P Carbone

Cancer Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation.
Arturo Orlacchio, Yasuko Kajimura, Lara Rizzotto, Anna Tessari, Shimaa H A Soliman, David P Carbone

J Exp Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular Vesicular Delta-Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis.
Hong Li, Chi-Ling Chiang, Kwang Joo Kwak, Hsin-Lun Lee, Xinyu Wang, David P Carbone

Adv Sci (Weinh)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Mesothelioma Mortality in the United States Between 1999 and 2020.
Alexander J Didier, Mingjia Li, Jinesh Gheeya, Asrar Alahmadi, Jacob Kaufman, David P Carbone

JTO Clin Res Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications.
Michal Harel, Nili Dahan, Coren Lahav, Eyal Jacob, Yehonatan Elon, David P Carbone

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancer.
Xiaoying Wang, Maoteng Duan, Po-Lan Su, Jianying Li, Jordan Krull, David P Carbone

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in vivo "turning model" reveals new RanBP9 interactions in lung macrophages.
Yasuko Kajimura, Shuxin Dong, Anna Tessari, Arturo Orlacchio, Alexandra Thoms, David P Carbone

Cell Death Discov· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, David P Carbone

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in therapeutic strategies for non-small cell lung cancer.
Po-Lan Su, Naoki Furuya, Alahmadi Asrar, Christian Rolfo, Zihai Li, David P Carbone

J Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches.
Alexander Rudich, Natalie Johns, Songzhu Zhao, Kenneth Chian, Po-Lan Su, David Carbone

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression.
Natalie Johns, Alexander Rudich, Songzhu Zhao, Kenneth Chian, Po-Lan Su, David Carbone

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types.
David R Gandara, Neeraj Agarwal, Shilpa Gupta, Samuel J Klempner, Miles C Andrews, David P Carbone

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis